All Outputs (2)

Implementation of a Pharmacogenomic Testing Service through Community Pharmacy in the Netherlands: Results from an Early Service Evaluation (2021)
Journal Article
Thornley, T., Esquivel, B., Wright, D. J., van den Dop, H., Kirkdale, C. L., & Youssef, E. (2021). Implementation of a Pharmacogenomic Testing Service through Community Pharmacy in the Netherlands: Results from an Early Service Evaluation. Pharmacy, 9(1), Article 38. https://doi.org/10.3390/pharmacy9010038

Community pharmacy services have evolved to include medical and pharmaceutical interventions alongside dispensing. While established pharmacogenomic (PGx) testing is available throughout the Netherlands, this is primarily based in hospital environmen... Read More about Implementation of a Pharmacogenomic Testing Service through Community Pharmacy in the Netherlands: Results from an Early Service Evaluation.

Estimating the potential impact of implementing pre-emptive pharmacogenetic testing in primary care across the UK (2021)
Journal Article
Youssef, E., Kirkdale, C. L., Wright, D. J., Guchelaar, H. J., & Thornley, T. (2021). Estimating the potential impact of implementing pre-emptive pharmacogenetic testing in primary care across the UK. British Journal of Clinical Pharmacology, 87(7), 2907-2925. https://doi.org/10.1111/bcp.14704

Aims: Pharmacogenetics (PGx) in the UK is currently implemented in secondary care for a small group of high-risk medicines. However, most prescribing takes place in primary care, with a large group of medicines influenced by commonly occurring geneti... Read More about Estimating the potential impact of implementing pre-emptive pharmacogenetic testing in primary care across the UK.